Apo-Sitagliptin/Metformin XR 50 mg

APO-SITAGLIPTIN/METFORMIN XR 50 MG is an extended-release tablet combining sitagliptin and metformin for managing type 2 diabetes. This medication supports blood sugar control as part of a broader treatment plan.

APO-SITAGLIPTIN/METFORMIN XR 50 MG is commonly used to help manage type 2 diabetes. Sitagliptin works by increasing insulin production, while metformin reduces glucose production in the liver. Together, they help regulate blood sugar levels. This medication is often prescribed for individuals who require dual therapy to achieve optimal glycemic control.

Common effects of APO-SITAGLIPTIN/METFORMIN XR 50 MG may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headaches or dizziness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

APO-SITAGLIPTIN/METFORMIN XR 50 MG should be taken as directed, typically with the evening meal to minimize gastrointestinal side effects. It is important to stay hydrated and maintain a balanced diet while using this medication. Individuals with kidney issues should consult a healthcare provider before use, as dosage adjustments may be necessary.

APO-SITAGLIPTIN/METFORMIN XR 50 MG may interact with certain medications, including other diabetes treatments, diuretics, and some antibiotics. Alcohol consumption should be limited, as it can increase the risk of lactic acidosis. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.